在非肝硬化重症患者中,高透胺血症
Marco Fiore1, Gianluigi Cosenza2, Francesco Coppolino2
1Department of Women, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples 80138, Campania, Italy. marco.fiore@hotmail.it.
World journal of hepatology
|December 10, 2025
概括
在重症监护室 (ICU) 患者中,肝酶的急性升高 (超超氨基酶血症) 通常表明系统性问题,而不是原发性肝病. 基于酶模式和新生物标志物的早期诊断和干预改善了结果.
科学领域:
- 关键护理医学 关键护理医学
- 肝病学 肝病学是一种肝病学.
- 生物标志物 生物标志物
背景情况:
- 超胺血症在非肝硬化ICU患者中很常见.
- 肝酶升高往往表明肝脏外疾病,而不是肝脏内在疾病.
研究的目的:
- 审查关于诊断和管理危重病患者的高转胺血症的证据.
- 探索新兴的生物标志物,以确定肝酶升高的原因.
主要方法:
- 在PubMed,EMBASE和CENTRAL (2010-2025) 的结构化文献搜索.
- 包括全文,英语,同行评审的文章.
主要成果:
- 肝脏缺氧损伤是ICU患者的主要原因,其标志着稳定后酶的快速下降.
- 药物诱导的肝损伤不常见,但在急性肝衰竭中是显著的.
- 败血症相关的肝损伤显示结合性高 bilirubinemia;亲肠营养相关的肝病包括胆固醇.
结论:
- 在ICU中氨基转移酶的升高反映了系统性痛苦.
- 使用临床数据,酶动力学和新生物标记物的模式识别方法可以指导治疗.
- 这些诊断策略的未来验证是有必要的.
关键词:
危急病患者的病情非常严重.药物诱导的肝损伤是药物诱导的过高输氨酸血症是什么意思缺氧性肝损伤是什么?在重症监护病房的重症监护病房.肝脏功能障碍 肝脏功能障碍亲肠道营养相关的肝病.败血症相关的肝功能障碍更多相关视频
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
200
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
200
Acute Pancreatitis II: Clinical Manifestations and Management
702
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
702
Esophageal Varices-II: Clinical Features and Management
340
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
340
Nephrotic Syndrome I : Introduction
469
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
469


